D.E. Shaw & Co’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $625K | Sell |
3,700
-5,000
| -57% | -$864K | ﹤0.01% | 3729 |
|
|
2025
Q4 | $1.59M | Buy |
8,700
+2,100
| +32% | +$293K | ﹤0.01% | 3223 |
|
|
2025
Q3 | $802K | Hold |
6,600
| – | – | ﹤0.01% | 3597 |
|
|
2025
Q2 | $689K | Hold |
6,600
| – | – | ﹤0.01% | 3478 |
|
|
2025
Q1 | $770K | Sell |
6,600
-17,700
| -73% | -$2.02M | ﹤0.01% | 3254 |
|
|
2024
Q4 | $2.06M | Buy |
24,300
+9,000
| +59% | +$828K | ﹤0.01% | 2711 |
|
|
2024
Q3 | $1.38M | Buy |
15,300
+5,100
| +50% | +$445K | ﹤0.01% | 3018 |
|
|
2024
Q2 | $821K | Hold |
10,200
| – | – | ﹤0.01% | 3311 |
|
|
2024
Q1 | $814K | Sell |
10,200
-24,400
| -71% | -$2.05M | ﹤0.01% | 3227 |
|
|
2023
Q4 | $2.75M | Hold |
34,600
| – | – | ﹤0.01% | 2418 |
|
|
2023
Q3 | $2.42M | Hold |
34,600
| – | – | ﹤0.01% | 2425 |
|
|
2023
Q2 | $2.49M | Buy |
34,600
+4,000
| +13% | +$295K | ﹤0.01% | 2455 |
|
|
2023
Q1 | $1.89M | Buy |
30,600
+20,600
| +206% | +$1.35M | ﹤0.01% | 2733 |
|
|
2022
Q4 | $771K | Buy |
+10,000
| New | +$598K | ﹤0.01% | 3619 |
|
|
2022
Q1 | – | Sell |
-90,000
| Closed | -$3.4M | – | 5525 |
|
|
2021
Q4 | $3.4M | Buy |
90,000
+60,000
| +200% | +$2.21M | ﹤0.01% | 2811 |
|
|
2021
Q3 | $989K | Hold |
30,000
| – | – | ﹤0.01% | 3604 |
|
|
2021
Q2 | $2.02M | Hold |
30,000
| – | – | ﹤0.01% | 2930 |
|
|
2021
Q1 | $1.7M | Hold |
30,000
| – | – | ﹤0.01% | 2730 |
|
|
2020
Q4 | $2.44M | Hold |
30,000
| – | – | ﹤0.01% | 2428 |
|
|
2020
Q3 | $2.14M | Hold |
30,000
| – | – | ﹤0.01% | 2352 |
|
|
2020
Q2 | $2.47M | Sell |
30,000
-10,000
| -25% | -$770K | ﹤0.01% | 2240 |
|
|
2020
Q1 | $2.35M | Buy |
40,000
+30,000
| +300% | +$2.44M | ﹤0.01% | 2029 |
|
|
2019
Q4 | $1.03M | Buy |
+10,000
| New | +$404K | ﹤0.01% | 2962 |
|
Other funds holding AXSM
VPM
VCM
DTC
